0001214659-23-012446.txt : 20230919
0001214659-23-012446.hdr.sgml : 20230919
20230919092410
ACCESSION NUMBER: 0001214659-23-012446
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230905
FILED AS OF DATE: 20230919
DATE AS OF CHANGE: 20230919
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Krogulski Kenneth
CENTRAL INDEX KEY: 0001695580
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33637
FILM NUMBER: 231262644
MAIL ADDRESS:
STREET 1: 2525 WEST END AVENUE, SUITE 950
CITY: NASHVILLE
STATE: TN
ZIP: 37203
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CUMBERLAND PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001087294
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2525 WEST END AVENUE
STREET 2: SUITE 950
CITY: NASHVILLE,
STATE: TN
ZIP: 37203
BUSINESS PHONE: 615-255-0068
MAIL ADDRESS:
STREET 1: 2525 WEST END AVENUE
STREET 2: SUITE 950
CITY: NASHVILLE
STATE: TN
ZIP: 37203
4
1
marketforms-62634.xml
PRIMARY DOCUMENT
X0508
4
2023-09-05
0001087294
CUMBERLAND PHARMACEUTICALS INC
CPIX
0001695580
Krogulski Kenneth
1600 WEST END AVE., SUITE 1300
NASHVILLE
TN
37203
true
false
false
false
1
Common Stock
2023-09-05
5
L
false
E
325
1.71
A
214019
D
Common Stock
2023-09-06
5
L
false
E
325
1.68
A
214344
D
Common Stock
2023-09-07
5
L
false
E
325
1.71
A
214669
D
Common Stock
2023-09-08
5
L
false
E
325
1.71
A
214994
D
Common Stock
2023-09-11
5
L
false
E
325
1.74
A
215319
D
Common Stock
2023-09-12
5
L
false
E
325
1.79
A
215644
D
Common Stock
2023-09-13
5
L
false
E
325
1.86
A
215969
D
Common Stock
2023-09-14
5
L
false
E
325
1.87
A
216294
D
Common Stock
2023-09-15
5
L
false
E
72
1.82
A
216366
D
The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023.
Kenneth J. Krogulski by /s/ John Hamm as attorney-in-fact
2023-09-19